Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Philip Lowry0
Elouard Benchikh0
Ivan McConnell0
Peter Fitzgerald0
Date of Patent
April 9, 2019
Patent Application Number
15130137
Date Filed
April 15, 2016
Patent Primary Examiner
Patent abstract
The current invention describes novel immunogens which are used in the production of novel antibodies with unique binding properties in that they cross-react with a variety of phenylpiperazine derivatives. These antibodies enable methods and kits to detect and/or determine phenylpiperazine derivatives (for example mCPP, TFMPP and MeOPP) in an in vitro sample which are advantageous over currently available analytical methods in terms of cost, ease of use, speed and sensitivity.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
